OppenheimerFunds’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $602K | Buy |
1,465
+37
| +3% | +$15.2K | ﹤0.01% | 1296 |
|
|
2018
Q4 | $533K | Sell |
1,428
-26
| -2% | -$9.7K | ﹤0.01% | 1348 |
|
|
2018
Q3 | $587K | Sell |
1,454
-267
| -16% | -$108K | ﹤0.01% | 1374 |
|
|
2018
Q2 | $594K | Sell |
1,721
-37,301
| -96% | -$12.9M | ﹤0.01% | 1353 |
|
|
2018
Q1 | $13.4M | Sell |
39,022
-6,596
| -14% | -$2.27M | 0.02% | 651 |
|
|
2017
Q4 | $17.2M | Sell |
45,618
-3,011
| -6% | -$1.13M | 0.02% | 628 |
|
|
2017
Q3 | $21.7M | Sell |
48,629
-7,945
| -14% | -$3.55M | 0.03% | 532 |
|
|
2017
Q2 | $27.8M | Sell |
56,574
-12,349
| -18% | -$6.07M | 0.03% | 451 |
|
|
2017
Q1 | $26.7M | Buy |
68,923
+6,778
| +11% | +$2.63M | 0.03% | 485 |
|
|
2016
Q4 | $22.8M | Sell |
62,145
-78,250
| -56% | -$28.7M | 0.03% | 539 |
|
|
2016
Q3 | $56.4M | Buy |
140,395
+26,974
| +24% | +$10.8M | 0.07% | 287 |
|
|
2016
Q2 | $39.6M | Buy |
113,421
+16,418
| +17% | +$5.73M | 0.05% | 374 |
|
|
2016
Q1 | $35M | Buy |
97,003
+96,196
| +11,920% | +$34.7M | 0.05% | 399 |
|
|
2015
Q4 | $441K | Buy |
+807
| New | +$441K | ﹤0.01% | 1334 |
|